Indications:
As an adjunct to general anesthesia to failitate endotracheal
intubation and to provide skeletal muscle relaxation during
surgery or mechanical ventilation.

Dosage:
Adult : 0.3 - 0.6 mg/ kg / dose will provide adequate relaxation
for about 15-35 min.
Children: In children over the age of one month is similar to that in
adults on the body weight base

Drug interaction:
Drugs which may enhance the neuromuscular blocking action of Atracurium Besylate include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine.
If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered.
The prior administration of succinylcholine does not enhance the duration, but quickens the onset and may increase the depth, of neuromuscular block induced by Atracurium Besylate. Atracurium Besylate should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block.

Packages:
Box Containing 5 Ampoules
in 2 concentrations : 25mg / 50 mg

Download Atrabesylate Flyer(PDF)